GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Infant Bacterial Therapeutics IBT B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

72.80

-1.09%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−SEK 65.2m

FY2016FY2025

Free cash flow

−SEK 72.3m

FY2016FY2025

Shareholders' equity

SEK 105.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue—SEK 4,000SEK 77,000SEK 12,000————SEK 238,000SEK 162,000
Gross profit—SEK 4,000SEK 77,000SEK 12,000——−SEK 816,000−SEK 816,000SEK 238,000−SEK 649,000
Research and developmentSEK 48.8mSEK 120.6mSEK 121.2mSEK 65.8mSEK 44.7mSEK 72.2mSEK 47.2mSEK 39.4mSEK 36.4mSEK 40.8m
Operating income−SEK 62.0m−SEK 139.9m−SEK 134.6m−SEK 65.8m−SEK 44.6m−SEK 71.9m−SEK 47.2m−SEK 39.4m−SEK 36.1m−SEK 38.1m
Net income−SEK 65.2m−SEK 136.9m−SEK 123.1m−SEK 65.5m−SEK 45.0m−SEK 72.3m−SEK 47.0m−SEK 40.6m−SEK 36.2m−SEK 38.1m
Diluted earnings per share-4.84-10.16-9.14-5.83-4.01-6.44-4.19-3.62-5.88-6.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 161.7mSEK 239.6mSEK 351.3mSEK 349.6mSEK 408.5mSEK 450.3mSEK 518.3mSEK 563.4mSEK 175.0mSEK 110.1m
Cash and short-term investmentsSEK 144.0mSEK 223.4mSEK 329.1mSEK 335.8mSEK 386.8mSEK 423.4mSEK 495.2mSEK 542.2mSEK 158.3mSEK 93.8m
Total liabilitiesSEK 56.4mSEK 69.3mSEK 46.2mSEK 17.9mSEK 13.2mSEK 10.2mSEK 7.9mSEK 6.7mSEK 6.7mSEK 4.9m
Shareholders' equitySEK 105.3mSEK 170.3mSEK 305.2mSEK 331.7mSEK 395.3mSEK 440.2mSEK 510.4mSEK 556.7mSEK 168.4mSEK 105.2m
Shares outstanding13m13m13m11m11m11m11m11m6m6m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 72.3m−SEK 113.1m−SEK 101.2m−SEK 85.8m−SEK 55.6m−SEK 58.4m−SEK 51.3m−SEK 47.4m−SEK 34.8m−SEK 39.7m
Capital spending————————−SEK 50,000—
Free cash flow−SEK 72.3m−SEK 113.1m−SEK 101.2m−SEK 85.8m−SEK 55.6m−SEK 58.4m−SEK 51.3m−SEK 47.4m−SEK 34.8m−SEK 39.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue——————−SEK 1,000—
Gross profit——————−SEK 1,000—
Operating income−SEK 30.2m−SEK 23.5m−SEK 20.5m−SEK 10.8m−SEK 20.1m−SEK 17.5m−SEK 37.4m−SEK 33.8m
Net income−SEK 29.7m−SEK 22.9m−SEK 19.2m−SEK 10.1m−SEK 19.2m−SEK 16.7m−SEK 33.8m−SEK 32.6m
Diluted earnings per share-2.21-1.70-1.43-0.75-1.42-1.24-2.51-2.42
Cash from operations−SEK 23.0m−SEK 12.0m−SEK 20.0m−SEK 8.0m−SEK 15.0m−SEK 27.0m−SEK 8.0m−SEK 50.0m
Total assetsSEK 120.2mSEK 143.1mSEK 161.7mSEK 178.2mSEK 193.2mSEK 207.9mSEK 239.6mSEK 239.3m
Cash and short-term investmentsSEK 108.6mSEK 131.9mSEK 144.0mSEK 165.3mSEK 176.3mSEK 191.8mSEK 223.4mSEK 226.2m
Shareholders' equitySEK 53.0mSEK 82.6mSEK 105.3mSEK 124.4mSEK 134.4mSEK 153.5mSEK 170.3mSEK 204.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-2.0%-2.9%11.6%
Net income-0.1%-2.1%12.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-10.4-5.3-3.4-3.0-5.8-6.0-11.9-13.6-6.1-2.2

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.